Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.560
+0.080 (1.79%)
At close: Oct 16, 2025, 4:00 PM EDT
4.620
+0.060 (1.32%)
After-hours: Oct 16, 2025, 7:53 PM EDT
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $95.69 million as of October 16, 2025. Its market cap has decreased by -30.21% in one year.
Market Cap
95.69M
Enterprise Value
143.51M
1-Year Change
-30.21%
Ranking
Category
Stock Price
$4.56
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $95.69M, a decrease of -83.54%. That is a compound annual growth rate of -14.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 95.70M | -1.44% |
| Dec 31, 2024 | 97.10M | 27.60% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
| Jul 31, 2014 | 581.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |